Advertisement
Home Tags Heart / Stroke-Related: Coronary-Artery Disease

Tag: Heart / Stroke-Related: Coronary-Artery Disease

For asymptomatic patients with type 2 diabetes

CCTA Has Prognostic Value in Asymptomatic T2DM Patients

0
Excellent long-term prognoses for patients with normal coronary arteries, non-obstructive CAD
For patients with type 2 diabetes and coronary artery disease

CABG Plus Optimal Medical Therapy Best in T2DM and CAD

0
During long-term follow-up, CABG + OMT linked to reduction in composite of death, MI, stroke
Increased coronary artery calcium

Coronary Artery Calcium Increased in Psoriasis Patients

0
Higher levels of coronary artery calcium in patients with psoriasis similar to that seen in type 2 diabetes
Physicians frequently under-recognize angina in their patients with coronary artery disease

Physician Under-Recognition of Angina Often Occurs

0
Predictors of physician under-recognition include heart failure and less-frequent angina
Routinely measured lipid fractions may be associated with the risk of coronary artery disease and diabetes

Lipid Fractions May Be Linked to Risk of CAD, Diabetes

0
Increase in LDL-C, triglycerides linked to higher CAD risk; LDL-C, HDL-C linked to lower risk of diabetes
Compared with femoral access for coronary interventions

Radial Bests Femoral Access for Coronary Interventions

0
Lower mortality, adverse cardiac events, bleeding seen across CAD patients
For patients with coronary artery disease enrolled in the Prospective Multicenter Imaging Study for Evaluation of Chest Pain

Similar Costs for CTA, Functional Diagnostic Testing in CAD

0
Similar costs for patients in computed tomographic angiography, functional testing arms of PROMISE
ASGR1 mutation carriers have reduced levels of non-high-density lipoprotein cholesterol and reduced risk of coronary artery disease

ASGR1 Mutation Linked to Reduced Levels of Non-HDL-C

0
Heterozygous mutation carriers have lower levels of non-HDL-C, reduced risk of coronary artery disease
For statin-treated patients with coronary heart disease

Renal Function Key to Cardiac Outcome in Statin-Treated CHD

0
Intrastudy stabilization, increase in eGFR linked to reduced MCVE rate in atorvastatin-treated patients
The American College of Cardiology and the American Heart Association Task Force on Clinical Practice Guidelines has updated the recommendations regarding duration of dual antiplatelet therapy for patients with coronary artery disease. The updated practice guideline was published online March 29 in the Journal of the American College of Cardiology.

Guidelines Updated on Duration of Dual Antiplatelet Tx in CAD

0
Longer-duration tx represents trade-off between decreased risk of cardiac events, increased bleeding